Leadership

The Board of Directors is responsible for the direction and completion of ongoing work of the organization defined by the ACMGF’s mission statement and strategic plan. ACMGF Board members are volunteers and elected by colleagues. Once approved, a member is eligible to serve a term commencing at the ACMG Annual Meeting. Responsibilities include, but are not limited to: fundraising and fiduciary governance, oversight of legal and ethical considerations, and strategic direction.

Professor Brynn Levy, MSc(Med), PhD, FACMG

Brynn Levy, M.Sc.(Med)., Ph.D., FACMG, is a Professor of Pathology and Cell Biology at the Columbia University Vagelos College of Physicians and Surgeons. He is also the Medical Director of the Clinical Cytogenetics Laboratory of New York-Presbyterian and a Co-Director of the Laboratory of Personalized Genomic Medicine in the Department of Pathology & Cell Biology at Columbia University. He is an early adopter of new technologies for both clinical and research purposes and actively works with groups like the American College of Medical Genetics (ACMG), College of American Pathologists (CAP), Cancer Genomics Consortium (CGC), and the International Society for Prenatal Diagnosis (ISPD) to establish national and international standards and guidelines for integration of new technologies for clinical use.

Dr. Levy recently served as the Genetics and Genomics Section Editor for the journal Prenatal Diagnosis and currently serves on multiple ACMG, CAP, and ClinGen committees. He is the current President of the ACMG Foundation and a past President and one of the founding Board members of the CGC. He also serves on the Board of Directors for the ISPD. He has over 200 peer-reviewed publications, book chapters and presentations and is actively involved in shaping the direction and professional activities of the field of clinical genetics and laboratory diagnostics.